Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 258 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2923 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-06-20 | 2023-07-05 | 195867 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2023-07-20 | 2023-10-04 | 199313 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2024-01-11 | 2024-08-30 | 215704 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2024-06-27 | 2024-08-08 | 231421 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2024-08-30 | 2024-10-17 | 236359 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2025-01-09 | 2025-02-20 | 247319 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2025-01-30 | 2025-02-06 | 249195 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2025-05-02 | 2025-11-13 | 256447 |
| TEVA-CLOBETASOL | 0.05% | OINTMENT | Resolved | 2025-05-15 | 2025-11-17 | 257510 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Actual shortage | 2017-08-17 | 2017-10-11 | 19683 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Actual shortage | 2017-08-17 | 2017-10-11 | 19688 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2020-03-26 | 2020-04-09 | 109623 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2020-07-30 | 2020-08-21 | 121503 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2021-08-13 | 2021-10-07 | 144108 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-08-18 | 2022-09-08 | 167191 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Resolved | 2022-12-08 | 2023-01-26 | 177520 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183364 |
| TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-02-16 | 2023-10-04 | 184946 |
| TEVA-CLONIDINE | 0.2MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195888 |
| TEVA-CLONIDINE | 0.025MG | TABLET | Actual shortage | 2023-10-05 | 2024-07-03 | 206416 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |